Buy this domain?
Click Here

June 2019
M T W T F S S
     
 12
3456789
10111213141516
17181920212223
24252627282930

Search

ato.my
Transfusion-associated graft-versus-host disease
Transfusion-associated graft-versus-host disease (TA-GvHD) is a rare complication of blood transfusion, in which the immunologically competent donor T
Graft-versus-host disease
Graft-versus-host disease (GvHD) is a medical complication following the receipt of transplanted tissue from a genetically different person. GvHD is commonly
Blood transfusion
gamma-irradiation as a method to prevent graft-versus-host disease (TA-GvHD). Before a recipient receives a transfusion, compatibility testing between donor
Hematopoietic stem cell transplantation
radiation or chemotherapy before the transplantation. Infection and graft-versus-host disease are major complications of allogeneic HSCT. Hematopoietic stem
Cryoprecipitate
acute lung injury, circulatory overload, transfusion-associated graft-versus-host disease, and post-transfusion purpura. Each unit (around 10 to 15 mL)
Anemia in pregnancy
transfusion associated graft versus host disease and febrile non-hemolytic transfusion reactions. Because of these risks, blood product transfusion should
Serious Hazards of Transfusion
from the product) to reduce the risk of transfusion-associated graft-versus-host disease and post-transfusion purpura in immunocompromised patients. SHOT's
Platelet transfusion
populations (those at risk of transfusion-associated graft versus host disease). Hillyer CD (2007). Blood Banking and Transfusion Medicine: Basic Principles
Fludarabine
patients susceptible to transfusion-associated graft versus host disease, an oftentimes fatal complication of blood transfusion. For this reason, all patients
Atopy
that reduced use of antibiotics and antipyretics is associated with a reduced risk of allergic disease in children. There is a strong genetic predisposition